Nalaganje...
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
BACKGROUND: Treatment of multidrug-resistant tuberculosis (MDR-TB) is complex, lengthy, and involves a minimum of four drugs termed a background regimen (BR), that have not previously been prescribed or that have proven susceptible to patient sputum culture isolates. In recent years, promising new t...
Shranjeno v:
| izdano v: | BMC Health Serv Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341441/ https://ncbi.nlm.nih.gov/pubmed/28270207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-017-2118-2 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|